nitrendipine has been researched along with Eye Disorders in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The test substance proved to be only mildly toxic after repeated (up to 3 months) oral administration." | 1.29 | Experimental studies on the toxicity of diperdipine following oral and parenteral application. ( Herzog, R; Leuschner, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herzog, R | 1 |
| Leuschner, J | 1 |
1 other study available for nitrendipine and Eye Disorders
| Article | Year |
|---|---|
Experimental studies on the toxicity of diperdipine following oral and parenteral application.
Topics: Administration, Oral; Animals; Blood Cell Count; Body Weight; Calcium Channel Blockers; Eye Diseases | 1995 |